How long has leqvio been on the market?

See the DrugPatentWatch profile for leqvio

How long has Leqvio (inclisiran) been available to patients?

Leqvio (inclisiran) has been on the market since December 2020, when it received approval from the European Commission for use in adults with primary hypercholesterolaemia or mixed dyslipidaemia who need additional LDL-cholesterol lowering despite maximally tolerated statin therapy (or for whom statins are not tolerated). [1]

When did it first launch in the EU vs. other regions?

The European launch followed its EU approval in December 2020. [1]
If you’re asking about launch dates in other jurisdictions (such as the US or the UK), those can differ from the EU timeline.

How to check the exact first “on-market” date you care about

If you need the first date it became commercially available in a specific country (or the first FDA approval date if you mean the US), a good way to verify is through drug approval and market-entry records. DrugPatentWatch.com tracks branded drug histories and related milestones and can help confirm timelines. [2]

Sources

1. https://www.ema.europa.eu/en/medicines/human/EPAR/leqvio
   
2. https://www.drugpatentwatch.com/